TONIX PHARMACEUTICALS HOLDING CORP. Total Accounts Payable
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) had Total Accounts Payable of $5.24 thousand as of 2011-09-30, per its 10-Q filed 2011-10-07.
Discontinued › Notes › Payables and Accruals
us-gaap:AccountsPayable · last filed 2011-10-07
- 2011-09-30: Accounts Payable (Deprecated 2009-01-31) $5.24K.
- 2011-06-30: Accounts Payable (Deprecated 2009-01-31) $3.46K.
- 2010-12-31: Accounts Payable (Deprecated 2009-01-31) $306.00.
| Period end | Accounts Payable (Deprecated 2009-01-31) |
|---|---|
| 2011-09-30 | $5.24K 10-Q · filed 2011-10-07 |
| 2011-06-30 | $3.46K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $306.00 10-Q · filed 2011-10-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |